Anixa Biosciences (ANIX) Treasury Shares (2023 - 2025)

Anixa Biosciences' (ANIX) quarterly Treasury Shares came in at $6000.0 in Q1 2025, little changed on a QoQ basis from $6000.0 in Q4 2024.

Anixa Biosciences (ANIX) Treasury Shares (2023 - 2025) Analysis & Trends

Anixa Biosciences (ANIX) has 2 years of Treasury Shares data on file, last reported at $6000.0 in Q1 2025.

Quarterly Treasury Shares rose 14900.0% year-over-year to $300000.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $300000.0 (up 14900.0% YoY) and the FY2025 annual result came in at $300000.0, up 14900.0% from the prior year.
Treasury Shares was little changed at $6000.0 in Q1 2025, from $6000.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $300000.0 in Q4 2025 to a low of $2000.0 in Q4 2023.
A 3-year average of $51666.7 and a median of $2000.0 in 2023 frame the typical range for Treasury Shares.
Annual changes were most pronounced in 2024 — Treasury Shares changed 0.0% — and 2025, when it surged 14900.0%.
Tracing ANIX's Treasury Shares over 3 years: stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then surged by 14900.0% to $300000.0 in 2025.
The last three Treasury Shares figures came in at $300000.0 (Q4 2025), $2000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	2.72 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	8.96 Mn
10	Anixa Biosciences	121.44 Mn	121.44 Mn	-	-

Download Data